Morgan Stanley Begins Coverage on Mettler-Toledo International (NYSE:MTD)

Analysts at Morgan Stanley assumed coverage on shares of Mettler-Toledo International (NYSE:MTD) in a research note issued to investors on Tuesday, Marketbeat reports. The brokerage set an “equal weight” rating and a $1,550.00 price target on the medical instruments supplier’s stock. Morgan Stanley’s target price suggests a potential upside of 7.89% from the company’s previous close.

Several other equities analysts have also recently weighed in on the company. Wells Fargo & Company lifted their price objective on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday, November 10th. Evercore ISI boosted their price target on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. JPMorgan Chase & Co. increased their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. Stifel Nicolaus raised their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a report on Monday, November 10th. Finally, Citigroup upped their price target on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Five investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, Mettler-Toledo International has an average rating of “Hold” and a consensus price target of $1,419.55.

Mettler-Toledo International Stock Down 0.7%

NYSE MTD opened at $1,436.71 on Tuesday. The company has a market capitalization of $29.35 billion, a P/E ratio of 35.83, a P/E/G ratio of 4.75 and a beta of 1.40. Mettler-Toledo International has a 12-month low of $946.69 and a 12-month high of $1,525.17. The firm has a 50-day moving average price of $1,380.65 and a two-hundred day moving average price of $1,280.35.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The company had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. During the same period last year, the firm earned $10.21 earnings per share. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Equities analysts expect that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Buying and Selling

In related news, insider La Guerroniere Marc De sold 6,880 shares of the firm’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $1,450.00, for a total transaction of $9,976,000.00. Following the sale, the insider owned 187 shares of the company’s stock, valued at $271,150. This trade represents a 97.35% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Patrick Kaltenbach sold 2,000 shares of the company’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the completion of the transaction, the chief executive officer directly owned 3,670 shares of the company’s stock, valued at approximately $5,367,375. The trade was a 35.27% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 19,565 shares of company stock worth $28,683,737 in the last ninety days. Insiders own 0.77% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in Mettler-Toledo International by 1.3% during the 3rd quarter. Vanguard Group Inc. now owns 2,591,173 shares of the medical instruments supplier’s stock worth $3,180,950,000 after acquiring an additional 34,466 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Mettler-Toledo International by 71.3% during the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after purchasing an additional 376,419 shares during the period. Capital International Investors grew its stake in shares of Mettler-Toledo International by 1.2% in the third quarter. Capital International Investors now owns 859,559 shares of the medical instruments supplier’s stock worth $1,055,203,000 after purchasing an additional 10,395 shares during the last quarter. Alliancebernstein L.P. grew its stake in shares of Mettler-Toledo International by 10.7% in the third quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock worth $974,633,000 after purchasing an additional 76,478 shares during the last quarter. Finally, Geode Capital Management LLC increased its holdings in Mettler-Toledo International by 0.6% in the second quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock valued at $681,489,000 after purchasing an additional 3,383 shares during the period. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.